Skip to main content
. 2024 Mar 5;8:268. Originally published 2023 Jun 21. [Version 2] doi: 10.12688/wellcomeopenres.19148.2

Figure 1. Overview of patient presentation and management, outlining timing of emergence of diabetic ketoacidosis after co-administration of empagliflozin and probenecid.

Figure 1.

Created with BioRender.com. DKA, diabetic ketoacidosis; DVT, deep vein thrombosis; HbA 1c, glycated haemoglobin; ICU, intensive care unit; KCl, potassium chloride; MDI, multiple daily injection; MR, modified release; OPAT, outpatient parenteral antibiotic therapy; PICC, peripherally inserted central catheter; SC, subcutaneous; TTE, transthoracic echocardiogram; VRIII, variable rate intravenous insulin infusion. Figure 1 was created with BioRender.com.